| (P1030) |
Down-regulation of the dendritic cell homing factors CCR7 and CCL21 via oxLDL negatively influences plaque progression |
|
T. Nickel, C. Summo, S. Pfeiler, R. Kopp, G. Meimarakis, Z. Sisic, R. David, I. Kaczmarek, M. Weis (München) |
| (P1031) |
TNFα enhances the vasoconstrictor potential of serotonin and thromboxane through impairment of endothelial function |
|
P. Kleinbongard, S. Schöner, K. Leineweber, D. Böse, T. F. M. Konorza, H. Eggebrecht, M. Haude, R. Erbel, G. Heusch (Essen, Neuss) |
| (P1032) |
Endothelial glycocalyx degradation occurs both in cardiac ischemia and hypoxia via activation of resident mast cells by the purine catabolite inosine |
|
B. F. Becker, J. Fischer, H. Hartmann, C. Sommerhoff, C. Chen, J. Tschoep, P. Conzen, M. Rehm, U. Welsch, T. Annecke (München) |
| (P1033) |
Role of serum & glucocorticoid inducible kinase 1 (SGK1) in the regulation of platelet function |
|
O. Borst, E.-M. Gehring, P. Münzer, T. Schönberger, S. T. Towhid, M. Elvers, A. Eylenstein, C. Leibrock, D. Kuhl, A. May, M. Gawaz, F. Lang (Tübingen, Hamburg) |
| (P1034) |
Der Einfluss von Flavonoiden auf die Stress-induzierte Thrombozytenaktivierung |
|
T. Nickel, J. Scherr, K. Lackermair, E. Hoster, M. Lambert, M. Halle, U. Wilbert-Lampen (München) |
| (P1035) |
Elevated C-reactive protein levels and high residual platelet aggregation under antiplatelet therapy are independent predictors of cardiovascular events in patients after coronary intervention. |
|
K. A. L. Müller, S. Aichele, M. Herkommer, B. Bigalke, K. Stellos, P. Htun, S. Fateh-Moghadam, A. May, M. Flather, M. Gawaz, T. Geisler (Tübingen; London, UK) |
| (P1036) |
Einfluss einer erhöhten Clopidogrel-Dosierung auf klinische Ereignisse bei Patienten mit hoher Plättchenreaktivität unter Standardtherapie nach Koronarintervention mit Drug-eluting Stent |
|
D. Trenk, C. M. Valina, K. Allgaier, W. Hochholzer, S. Leggewie, C. Stratz, R.-P. Kienzle, H. J. Büttner, F.-J. Neumann (Bad Krozingen) |
| (P1037) |
Ergebnisse der MIDCAB-Operation bei Patienten mit Hauptstammstenose |
|
C. Grothusen, G. Hoffmann, S. Fraund-Cremer, R. Petzina, J. Schöttler, A. Kowalski, J. Cremer (Kiel) |
| (P1038) |
Increased Predictivity of Mortality by Combined Use of High-Sensitivity Cardiac Troponin T and N-Terminal Probrain Natriuretic Peptide in Stable Coronary Artery Disease |
|
S. Schulz, G. Ndrepepa, S.-L. Braun, J. Mehilli, S. Massberg, J. Pache, A. Schömig, A. Kastrati (München) |
| (P1039) |
CARDIoGRAM consortium: Thirteen novel genetic loci affecting risk of coronary artery disease |
|
J. Erdmann (Lübeck) |
| (P1040) |
Blood-oxygen-level-dependent magnetic resonance imaging in comparison to contrast-enhanced adenosine-perfusion for detection of inducible myocardial ischemia |
|
P. Bernhardt, R. Gradinger, V. Rasche, W. Rottbauer (Ulm) |
| (P1041) |
Comparison of Exercise Electrocardiography and CMR Stress Perfusion Imaging for the Detection of Coronary Artery Disease in Women |
|
S. Greulich, U. Sechtem, H. Mahrholdt, H. Vogelsberg, E.-M. Kispert, I. Klem (Stuttgart; Durham, US) |
| (P1042) |
Unterschiede in der Chemokinrezeptor-Expression auf peripheren Monozyten nach elektiver Stent-Implantation |
|
C. Eulert, F. Hittler, D. Berliner, G. Ertl, J. Bauersachs, A. Schäfer (Würzburg, Hannover) |
| (P1043) |
Plasma levels of amyloid beta peptides 1-40 and 1-42 are novel biomarkers of coronary artery disease |
|
K. Stellos, K. Sopova, D. Stakos, B. Bigalke, C. Laske, M. Gawaz (Tübingen) |